Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yunli Zhou, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R03AG026060 (ZHOU, YUNLI) Jul 1, 2006 - Jun 30, 2008
    NIH
    Regulation of Cellular Senescence by MEG3 RNA
    Role: Principal Investigator
  2. F32CA088519 (ZHOU, YUNLI) Jan 17, 2000
    NIH
    FUNCTIONAL STUDIES OF TYPE I ACTIVIN RECEPTOR ISOFORMS
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Zhao W, Jiang X, Weisenthal K, Ma J, Botticelli EM, Zhou Y, Hedley-Whyte ET, Wang B, Swearingen B, Soberman RJ, Klibanski A, Zhang X. High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. Front Oncol. 2022; 12:875122. PMID: 35646715; PMCID: PMC9136140.
    Citations:    
  2. Zhou J, Hu Y, Zhu W, Nie C, Zhao W, Faje AT, Labelle KE, Swearingen B, Lee H, Hedley-Whyte ET, Zhang X, Jones PS, Miller KK, Klibanski A, Zhou Y, Soberman RJ. Sprouting Angiogenesis in Human Pituitary Adenomas. Front Oncol. 2022; 12:875219. PMID: 35600354; PMCID: PMC9117625.
    Citations:    
  3. Xi Z, Jones PS, Mikamoto M, Jiang X, Faje AT, Nie C, Labelle KE, Zhou Y, Miller KK, Soberman RJ, Zhang X. The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas. Front Endocrinol (Lausanne). 2021; 12:726448. PMID: 34745002; PMCID: PMC8566912.
    Citations: 1     Fields:    Translation:Humans
  4. Bauer NC, Yang A, Wang X, Zhou Y, Klibanski A, Soberman RJ. A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3. J Biol Chem. 2021 Jan-Jun; 296:100540. PMID: 33722609.
    Citations: 1     Fields:    Translation:HumansCells
  5. Zhu W, Botticelli EM, Kery RE, Mao Y, Wang X, Yang A, Wang X, Zhou J, Zhang X, Soberman RJ, Klibanski A, Zhou Y. Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus. Dev Biol. 2019 11 01; 455(1):10-18. PMID: 31301299.
    Citations: 3     Fields:    Translation:AnimalsCells
  6. Sommerkamp P, Renders S, Ladel L, Hotz-Wagenblatt A, Schönberger K, Zeisberger P, Przybylla A, Sohn M, Zhou Y, Klibanski A, Cabezas-Wallscheid N, Trumpp A. The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells. Sci Rep. 2019 02 14; 9(1):2110. PMID: 30765776.
    Citations: 5     Fields:    Translation:AnimalsCells
  7. Chunharojrith P, Nakayama Y, Jiang X, Kery RE, Ma J, De La Hoz Ulloa CS, Zhang X, Zhou Y, Klibanski A. Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line. Mol Cell Endocrinol. 2015 Nov 15; 416:27-35. PMID: 26284494; PMCID: PMC4605874.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  8. Zhou Y, Zhang X, Klibanski A. Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol. 2014; 386(1-2):16-33.
  9. Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 2012 Jun; 48(3):R45-53. PMID: 22393162.
    Citations: 348     Fields:    Translation:HumansAnimalsCells
  10. Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y, Rice KA, Tessa Hedley-Whyte E, Swearingen B, Klibanski A. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol. 2011 Oct; 179(4):2120-30. PMID: 21871428; PMCID: PMC3181372.
    Citations: 46     Fields:    Translation:HumansCells
  11. Zhou Y, Cheunsuchon P, Nakayama Y, Lawlor MW, Zhong Y, Rice KA, Zhang L, Zhang X, Gordon FE, Lidov HG, Bronson RT, Klibanski A. Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development. 2010 Aug; 137(16):2643-52. PMID: 20610486.
    Citations: 78     Fields:    Translation:AnimalsCells
  12. Gordon FE, Nutt CL, Cheunsuchon P, Nakayama Y, Provencher KA, Rice KA, Zhou Y, Zhang X, Klibanski A. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology. 2010 Jun; 151(6):2443-52. PMID: 20392836; PMCID: PMC2875815.
    Citations: 76     Fields:    Translation:Animals
  13. Zhang X, Zhou Y, Klibanski A. Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach. Mol Cell Endocrinol. 2010 Sep 15; 326(1-2):40-7. PMID: 20211686; PMCID: PMC2904873.
    Citations: 11     Fields:    Translation:HumansCells
  14. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010 Mar 15; 70(6):2350-8. PMID: 20179190.
    Citations: 155     Fields:    Translation:HumansCells
  15. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010 Mar; 151(3):939-47. PMID: 20032057; PMCID: PMC2840681.
    Citations: 157     Fields:    Translation:HumansCells
  16. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2008 Oct; 93(10):4119-25. PMID: 18628527; PMCID: PMC2579639.
    Citations: 66     Fields:    Translation:HumansCells
  17. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007 Aug 24; 282(34):24731-42. PMID: 17569660.
    Citations: 307     Fields:    Translation:HumansCells
  18. Ansell PJ, Zhou Y, Schjeide BM, Kerner A, Zhao J, Zhang X, Klibanski A. Regulation of growth hormone expression by Delta-like protein 1 (Dlk1). Mol Cell Endocrinol. 2007 Jun 15; 271(1-2):55-63. PMID: 17485162; PMCID: PMC1974851.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  19. Batista DL, Zhang X, Gejman R, Ansell PJ, Zhou Y, Johnson SA, Swearingen B, Hedley-Whyte ET, Stratakis CA, Klibanski A. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab. 2006 Nov; 91(11):4482-8. PMID: 16940446.
    Citations: 48     Fields:    Translation:HumansCells
  20. Zhao J, Zhang X, Zhou Y, Ansell PJ, Klibanski A. Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region. Int J Biochem Cell Biol. 2006; 38(10):1808-20. PMID: 16793321.
    Citations: 29     Fields:    Translation:HumansCells
  21. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab. 2005 Apr; 90(4):2179-86. PMID: 15644399.
    Citations: 84     Fields:    Translation:HumansCells
  22. Zhou Y, Scolavino S, Funderburk SF, Ficociello LF, Zhang X, Klibanski A. Receptor internalization-independent activation of Smad2 in activin signaling. Mol Endocrinol. 2004 Jul; 18(7):1818-26. PMID: 15087470.
    Citations: 10     Fields:    Translation:AnimalsCells
  23. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003 Nov; 88(11):5119-26. PMID: 14602737.
    Citations: 187     Fields:    Translation:HumansCells
  24. Hu SX, Wang S, Wang JP, Mills GB, Zhou Y, Xu HJ. Expression of endogenous granzyme B in a subset of human primary breast carcinomas. Br J Cancer. 2003 Jul 07; 89(1):135-9. PMID: 12838314; PMCID: PMC2394226.
    Citations: 12     Fields:    Translation:HumansCells
  25. Zhou Y, Mehta KR, Choi AP, Scolavino S, Zhang X. DNA damage-induced inhibition of securin expression is mediated by p53. J Biol Chem. 2003 Jan 03; 278(1):462-70. PMID: 12403781.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  26. Danila DC, Zhang X, Zhou Y, Haidar JN, Klibanski A. Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells. J Clin Endocrinol Metab. 2002 Oct; 87(10):4741-6. PMID: 12364468.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  27. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab. 2002 Mar; 87(3):1262-7. PMID: 11889197.
    Citations: 57     Fields:    Translation:Humans
  28. Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X, Klibanski A. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling. Mol Endocrinol. 2000 Dec; 14(12):2066-75. PMID: 11117535.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  29. Danila DC, Zhang X, Zhou Y, Dickersin GR, Fletcher JA, Hedley-Whyte ET, Selig MK, Johnson SR, Klibanski A. A human pituitary tumor-derived folliculostellate cell line. J Clin Endocrinol Metab. 2000 Mar; 85(3):1180-7. PMID: 10720059.
    Citations: 13     Fields:    Translation:HumansCells
  30. Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J, Hu SX. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 1997 Nov 20; 15(21):2589-96. PMID: 9399646.
    Citations: 38     Fields:    Translation:Humans
  31. Hu SX, Ji W, Zhou Y, Logothetis C, Xu HJ. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res. 1997 Aug 15; 57(16):3339-43. PMID: 9269991.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  32. Li J, Hu SX, Perng GS, Zhou Y, Xu K, Zhang C, Seigne J, Benedict WF, Xu HJ. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene. 1996 Dec 05; 13(11):2379-86. PMID: 8957079.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  33. Xu HJ, Zhou Y, Seigne J, Perng GS, Mixon M, Zhang C, Li J, Benedict WF, Hu SX. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res. 1996 May 15; 56(10):2245-9. PMID: 8625292.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  34. Xu HJ, Xu K, Zhou Y, Li J, Benedict WF, Hu SX. Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):9837-41. PMID: 7937901; PMCID: PMC44912.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  35. Zhou Y, Li J, Xu K, Hu SX, Benedict WF, Xu HJ. Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sci U S A. 1994 May 10; 91(10):4165-9. PMID: 8183886; PMCID: PMC43745.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zhou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (218)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.